Compass Therapeutics(CMPX)
Focus: Compass Therapeutics is a publicly traded Boston-based biotech focused on antibody therapies and psychedelic-assisted treatments across oncology and neurology indications. The company is in early-stage clinical development with a diversified pipeline but minimal commercial revenue.
Profile data last refreshed 8h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
4
Should You Work at Compass Therapeutics?
AI assessmentCompass offers meaningful science exposure in emerging therapeutic modalities but carries material execution risk and hiring constraints; suitable only for risk-tolerant candidates committed to early-stage biotech with multi-year value creation horizons.
Why Work Here
- Access to cutting-edge antibody engineering and early-stage oncology programs (CTX-009 in Phase 2/3 for biliary tract cancer with recent BLA-targeting momentum)
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$850K
Pipeline & Clinical Trials
Freedom SCS System
Back PainVideogame
Doping in SportClinical Trials (1)
Help build intelligence for Compass Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.